By Dave Simpson ( February 19, 2019, 11:25 PM EST) -- In its second split decision in the past month, the U.S. Federal Trade Commission announced Tuesday that Germany's Fresenius Medical Care AG & Co. can go forward with its $2 billion deal for Massachusetts-based medical technology company NxStage Medical Inc. with a divestment....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.